iCardiac Technologies
Latest round
- Series B
Last raised
- Oct 2007
Total raised
- $15M
Investors
- 4
About iCardiac Technologies
iCardiac Technologies, Inc.Founded in 2006 in Rochester, US, iCardiac Technologies, Inc. provides cardiac safety assessments utilizing advanced ECG analysis for clinical trials. The company has undergone changes in business strategy to enhance its service offerings. It was acquired by ERT Clinical in December 2017, with terms of the sale undisclosed. The founder's history is not detailed in available resources.iCardiac Technologies, Inc. provides specialized cardiac safety assessments and ECG data management services for the pharmaceutical industry. Their offerings include comprehensive ECG analysis, reporting, and data management solutions tailored to meet the needs of clinical trials, ensuring regulatory compliance and data integrity.iCardiac Technologies, Inc. generates revenue through a service-based model that offers cardiac safety assessments and ECG analysis for clinical trials. The revenue is derived from contracts with pharmaceutical and biotech companies that require rigorous cardiac evaluation services as part of their drug development pipeline. aims to enhance its service portfolio and expand its market reach. The company plans to introduce new ECG analysis technologies to improve data accuracy and efficiency. Additionally, iCardiac is targeting growth into European and Asian markets by 2025, leveraging its acquisition by ERT Clinical to integrate its services into broader clinical trial solutions, thereby strengthening its competitive position in the industry.
Who invested in iCardiac Technologies
4 investors across 3 rounds
See all investors in iCardiac Technologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about iCardiac Technologies
Who invested in iCardiac Technologies?
iCardiac Technologies has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has iCardiac Technologies raised?
iCardiac Technologies has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did iCardiac Technologies last raise money?
iCardiac Technologies's most recent round on record is a Series B, in Oct 2007.
What does iCardiac Technologies do?
iCardiac Technologies is a biotechnology company.
Where is iCardiac Technologies headquartered?
iCardiac Technologies is headquartered in Rochester, US.
Which VCs invest in companies like iCardiac Technologies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at iCardiac Technologies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like iCardiac Technologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.